drugset / Trial / NCT04987463
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of the study is to evaluate the efficacy, tolerability, and safety of vigabatrin versus rapamycin as a preventive treatment in infants with Tuberous Sclerosis Complex (TSC).
Timeline
- Start
- 2021-05-07
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rapamycin | Small molecule | — | Oral |
| Subject | Vigabatrin | Small molecule | — | Oral |